Literature DB >> 8299585

Regulation of myosin isozyme expression by vitamin D3 deficiency and 1,25-dihydroxyvitamin D3 in the rat heart.

T D O'Connell1, R E Weishaar, R U Simpson.   

Abstract

In this report, we demonstrate a significant inverse correlation between contractility and serum 1,25-dihydroxyvitamin D3 [1,25-(OH)2D3] levels and no correlation between contractility and serum levels of calcium, phosphate, or PTH. We also examined myosin isozyme distribution in vitamin D3-deficient rats, because myosin isozyme distribution can alter contractility. There was a significant increase in the levels of the V1 myosin isozyme in animals raised on a vitamin D3-deficient diet that maintained normal serum calcium and phosphate levels. There was no difference in the relative myosin isozyme distribution in animals raised on a hypocalcemia-yielding vitamin D3-deficient diet vs. animals raised on a control diet. As increased contractility has been observed in both groups of vitamin D3-deficient animals, a shift in myosin isozyme distribution cannot solely explain the increase in contractility previously observed in the vitamin D3-deficient rat heart. To determine whether 1,25-(OH)2D3 directly regulates myosin isozyme levels, we analyzed myosin isozyme distribution in primary cultures of ventricular myocytes. We found that 1,25-(OH)2D3 reduces total myosin levels, but does not alter myosin isozyme distribution. Thus, we show that the influence of vitamin D3 status on myosin isozyme expression in the intact rat involves a complex regulatory system of direct and indirect effects.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8299585     DOI: 10.1210/endo.134.2.8299585

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  5 in total

1.  Preventing progression of cardiac hypertrophy and development of heart failure by paricalcitol therapy in rats.

Authors:  Soochan Bae; Bhargavi Yalamarti; Qingen Ke; Sangita Choudhury; Hyeon Yu; S Ananth Karumanchi; Paul Kroeger; Ravi Thadhani; Peter M Kang
Journal:  Cardiovasc Res       Date:  2011-05-11       Impact factor: 10.787

2.  Doxercalciferol, a pro-hormone of vitamin D, prevents the development of cardiac hypertrophy in rats.

Authors:  Jun H Choi; Qingen Ke; Soochan Bae; Ji Yoo Lee; Yu Jin Kim; Ui Kyoung Kim; Cynthia Arbeeny; Ravi Thadhani; Peter M Kang
Journal:  J Card Fail       Date:  2011-09-09       Impact factor: 5.712

3.  Vitamin D signaling pathway plays an important role in the development of heart failure after myocardial infarction.

Authors:  Soochan Bae; Sylvia S Singh; Hyeon Yu; Ji Yoo Lee; Byung Ryul Cho; Peter M Kang
Journal:  J Appl Physiol (1985)       Date:  2013-02-21

4.  1,25(OH)2 vitamin D3, and retinoic acid antagonize endothelin-stimulated hypertrophy of neonatal rat cardiac myocytes.

Authors:  J Wu; M Garami; T Cheng; D G Gardner
Journal:  J Clin Invest       Date:  1996-04-01       Impact factor: 14.808

5.  Identification of Novel Non-secosteroidal Vitamin D Receptor Agonists with Potent Cardioprotective Effects and devoid of Hypercalcemia.

Authors:  Santosh A Khedkar; Mohammed A Samad; Sangita Choudhury; Ji Yoo Lee; Dongsheng Zhang; Ravi I Thadhani; S Ananth Karumanchi; Alan C Rigby; Peter M Kang
Journal:  Sci Rep       Date:  2017-08-16       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.